NO803660L - Hybridcellelinje for fremstilling av monoklonalt antistoff til et antigen. - Google Patents

Hybridcellelinje for fremstilling av monoklonalt antistoff til et antigen.

Info

Publication number: NO803660L
Authority: NO; Norway
Prior art keywords: monoclonal antibody; cell line; antigen; hybrid cell; manufacturing monoclonal
Prior art date: 1979-12-04

Application number

NO803660A

Other languages

English (en)

Other versions

NO159887C (no

NO159887B (no

Inventor

Patrick Chung-Shu Kung

Gideon Goldstein

Original Assignee

Ortho Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-12-04

Filing date

1980-12-03

Publication date

1981-06-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22277970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO803660(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1980-12-03 Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp

1981-06-05 Publication of NO803660L publication Critical patent/NO803660L/no

1988-11-07 Publication of NO159887B publication Critical patent/NO159887B/no

1989-02-15 Publication of NO159887C publication Critical patent/NO159887C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2881—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD71
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Hybrid Cells (AREA)

NO803660A 1979-12-04 1980-12-03 Monoklonalt antistoff. NO159887C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/100,071 US4364934A (en)	1979-12-04	1979-12-04	Monoclonal antibody to a human early thymocyte antigen and methods for preparing same

Publications (3)

Publication Number	Publication Date
NO803660L true NO803660L (no)	1981-06-05
NO159887B NO159887B (no)	1988-11-07
NO159887C NO159887C (no)	1989-02-15

Family

ID=22277970

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO803660A NO159887C (no)	1979-12-04	1980-12-03	Monoklonalt antistoff.

Country Status (20)

Country	Link
US (1)	US4364934A (no)
EP (1)	EP0030814B1 (no)
JP (2)	JPS5695122A (no)
AT (1)	ATE13693T1 (no)
AU (1)	AU545181B2 (no)
CA (1)	CA1175367A (no)
DE (2)	DE3070745D1 (no)
DK (1)	DK153891C (no)
ES (1)	ES8301636A1 (no)
FI (1)	FI75599C (no)
HK (1)	HK24186A (no)
IE (1)	IE50724B1 (no)
IL (1)	IL61621A (no)
MY (1)	MY8600518A (no)
NO (1)	NO159887C (no)
NZ (1)	NZ195648A (no)
PH (1)	PH17490A (no)
PT (1)	PT72145B (no)
YU (1)	YU45077B (no)
ZA (1)	ZA807562B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4691010A (en) *	1979-12-04	1987-09-01	Ortho Pharmaceutical Corporation	Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen, antibody, and methods
US4624925A (en) *	1979-12-04	1986-11-25	Ortho Pharmaceutical Corporation	Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods
US4434156A (en)	1981-10-26	1984-02-28	The Salk Institute For Biological Studies	Monoclonal antibodies specific for the human transferrin receptor glycoprotein
USRE32011E (en) *	1981-12-14	1985-10-22	Scripps Clinic And Research Foundation	Ultrapurification of factor VIII using monoclonal antibodies
US4579827A (en) *	1983-03-11	1986-04-01	Sloan-Kettering Institute For Cancer Research	Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
JPS60231699A (ja) *	1983-11-09	1985-11-18	Aichiken	正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
FR2560212B1 (fr) *	1984-02-24	1989-12-29	Unicet	Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4562003A (en) *	1984-10-26	1985-12-31	California Biotechnology, Inc.	Monoclonal antibodies against alveolar surfactant protein
US5431897A (en) *	1985-04-19	1995-07-11	Sloan-Kettering Institute For Cancer Research	Method of imaging colorectal carcinoma lesion and composition for use therein
US4970299A (en) *	1986-07-03	1990-11-13	Sloan-Kettering Institute For Cancer Research	Monoclonal antibodies selective for prostate cancer
US5100777A (en) *	1987-04-27	1992-03-31	Tanox Biosystems, Inc.	Antibody matrix device and method for evaluating immune status
US5085985A (en) *	1987-11-12	1992-02-04	Becton Dickinson & Co.	Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
US5601819A (en) *	1988-08-11	1997-02-11	The General Hospital Corporation	Bispecific antibodies for selective immune regulation and for selective immune cell binding
US5252711A (en) *	1989-06-01	1993-10-12	The Gillette Company	Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof
SE503225C2 (sv) *	1991-10-30	1996-04-22	Leif Lindholm Konsult Ab	Virus-antikroppskomplex för införing av virus i mammalieceller
BR9610050A (pt)	1995-08-16	1999-10-13	Zeneca Ltd	Conjugado,sitemas de dois componentes combinados destinados a uso em um hospedeiro, compostos ou um sal destes famaceuticamente aceitavel,enzima,sequencia de polinucleotìdeos e de02 nucleotìdeos,vetor, célula hospedeira,processos de producão de uma enzima e de um conjugado e de tratamento de célulasneoplásticas em um hospedeiro,composicão farmaceutica e plasmìdeo
EP1034003A4 (en)	1997-11-24	2004-07-14	Johnson T Wong	METHODS FOR TREATING HIV OR OTHER INFECTIONS USING A T CELL ACTIVATOR OR A VIRAL ACTIVATOR AND ANTIRETROVIRAL COMBINATION THERAPY
US7653260B2 (en)	2004-06-17	2010-01-26	Carl Zeis MicroImaging GmbH	System and method of registering field of view
US8582924B2 (en)	2004-06-30	2013-11-12	Carl Zeiss Microimaging Gmbh	Data structure of an image storage and retrieval system
TWI726879B (zh)	2015-05-04	2021-05-11	美商Ｃｙｔｏｍｘ生物製藥公司	抗ｃｄ７１抗體類、可活化之抗ｃｄ７１抗體類及使用彼等之方法
WO2025024334A1 (en)	2023-07-21	2025-01-30	Marrow Therapeutics, Inc.	Hematopoietic cell targeting conjugates and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4196265A (en) *	1977-06-15	1980-04-01	The Wistar Institute	Method of producing antibodies
US4172124A (en) *	1978-04-28	1979-10-23	The Wistar Institute	Method of producing tumor antibodies
US4284412A (en) *	1979-07-13	1981-08-18	Ortho Diagnostics, Inc.	Method and apparatus for automated identification and enumeration of specified blood cell subclasses

1979
- 1979-12-04 US US06/100,071 patent/US4364934A/en not_active Expired - Lifetime
1980
- 1980-11-21 CA CA000365176A patent/CA1175367A/en not_active Expired
- 1980-11-25 NZ NZ195648A patent/NZ195648A/en unknown
- 1980-12-02 AU AU64961/80A patent/AU545181B2/en not_active Expired
- 1980-12-03 ES ES497424A patent/ES8301636A1/es not_active Expired
- 1980-12-03 DK DK517280A patent/DK153891C/da active
- 1980-12-03 DE DE8080304349T patent/DE3070745D1/de not_active Expired
- 1980-12-03 EP EP80304349A patent/EP0030814B1/en not_active Expired
- 1980-12-03 IE IE2510/80A patent/IE50724B1/en not_active IP Right Cessation
- 1980-12-03 AT AT80304349T patent/ATE13693T1/de active
- 1980-12-03 IL IL61621A patent/IL61621A/xx not_active IP Right Cessation
- 1980-12-03 NO NO803660A patent/NO159887C/no not_active IP Right Cessation
- 1980-12-03 DE DE198080304349T patent/DE30814T1/de active Pending
- 1980-12-03 PT PT72145A patent/PT72145B/pt unknown
- 1980-12-03 YU YU3064/80A patent/YU45077B/xx unknown
- 1980-12-03 PH PH24939A patent/PH17490A/en unknown
- 1980-12-03 FI FI803756A patent/FI75599C/fi not_active IP Right Cessation
- 1980-12-03 ZA ZA00807562A patent/ZA807562B/xx unknown
- 1980-12-04 JP JP17032680A patent/JPS5695122A/ja active Granted
1986
- 1986-04-03 HK HK241/86A patent/HK24186A/xx not_active IP Right Cessation
- 1986-12-30 MY MY518/86A patent/MY8600518A/xx unknown
1988
- 1988-05-17 JP JP63118391A patent/JPS6463376A/ja active Granted

Also Published As

Publication number	Publication date
DE3070745D1 (en)	1985-07-11
ES497424A0 (es)	1983-01-01
CA1175367A (en)	1984-10-02
AU6496180A (en)	1981-06-11
IE50724B1 (en)	1986-06-25
JPH0159869B2 (no)	1989-12-20
AU545181B2 (en)	1985-07-04
FI803756L (fi)	1981-06-05
DE30814T1 (de)	1984-07-19
NZ195648A (en)	1984-07-06
PT72145B (en)	1982-07-05
JPS6463376A (en)	1989-03-09
IL61621A (en)	1984-07-31
HK24186A (en)	1986-04-11
DK153891C (da)	1989-02-20
DK153891B (da)	1988-09-19
IE802510L (en)	1981-06-04
NO159887C (no)	1989-02-15
FI75599B (fi)	1988-03-31
EP0030814A3 (en)	1981-12-30
PT72145A (en)	1981-01-01
US4364934A (en)	1982-12-21
MY8600518A (en)	1986-12-31
YU306480A (en)	1984-04-30
EP0030814A2 (en)	1981-06-24
ZA807562B (en)	1982-07-28
FI75599C (fi)	1988-07-11
DK517280A (da)	1981-06-05
PH17490A (en)	1984-09-04
JPS5695122A (en)	1981-08-01
ES8301636A1 (es)	1983-01-01
EP0030814B1 (en)	1985-06-05
ATE13693T1 (de)	1985-06-15
NO159887B (no)	1988-11-07
YU45077B (en)	1992-03-10
JPS6363557B2 (no)	1988-12-07

Publication	Publication Date	Title
NO803661L (no)	1981-06-05	Hybridcellelinje for fremstilling av monoklonalt antistoff til et humant prothymocyttantigen
NO159883C (no)	1989-02-15	Monoklonalt antistoff.
NO159882C (no)	1989-02-15	Monoklonalt antistoff.
NO810034L (no)	1981-07-09	Hybrid cellelinje for fremstilling av monoklonalt antistoff til et t-celleantigen hos mennesker, samt antistoff
NO159885C (no)	1989-02-15	Monoklonalt antistoff.
NO803660L (no)	1981-06-05	Hybridcellelinje for fremstilling av monoklonalt antistoff til et antigen.
NO803659L (no)	1981-06-05	Hybridcellelinje for fremstilling av monoklonalt antistoff til et antigen.

Legal Events

Date	Code	Title	Description
2001-01-29	MK1K	Patent expired	Free format text: EXPIRED IN DECEMBER 2000